What is CAMP4 Therapeutics Corporation Common Stock's Market Cap?

CAMP4 Therapeutics Corporation Common Stock's Market Cap is $276.1M, based on as-reported figures from SEC (XBRL) filings.

What is CAMP4 Therapeutics Corporation Common Stock's Price / Sales?

CAMP4 Therapeutics Corporation Common Stock's Price / Sales is 65.5×, based on as-reported figures from SEC (XBRL) filings.

What is CAMP4 Therapeutics Corporation Common Stock's Revenue (TTM)?

CAMP4 Therapeutics Corporation Common Stock's Revenue (TTM) is $4.2M, based on as-reported figures from SEC (XBRL) filings.

What is CAMP4 Therapeutics Corporation Common Stock's Net Income (TTM)?

CAMP4 Therapeutics Corporation Common Stock's Net Income (TTM) is -$107.2M, based on as-reported figures from SEC (XBRL) filings.

What is CAMP4 Therapeutics Corporation Common Stock's Diluted EPS (TTM)?

CAMP4 Therapeutics Corporation Common Stock's Diluted EPS (TTM) is -1.71, based on as-reported figures from SEC (XBRL) filings.

What is CAMP4 Therapeutics Corporation Common Stock's EBITDA Margin?

CAMP4 Therapeutics Corporation Common Stock's EBITDA Margin is -1211.0%, based on as-reported figures from SEC (XBRL) filings.

CAMP4 Therapeutics Corporation Common Stock (CAMP) Financial Statements

CAMP4 Therapeutics Corporation Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00L2CHQ99

XNAS · usd

4.40▼ 0.01 (-0.23%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value—

Trailing P/E—

Price / Sales

EV / Revenue—

EV / EBITDA—

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt—

Trading Information

Previous Close4.41

Day's Range4.30 – 4.53

52-Week Range1.46 – 7.75

Volume280.2K

Avg Volume264.6K

Share Statistics

Shares Outstanding

Employees48

ExchangeXNAS

Listed2024-10-11

Share count as of August 12, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about CAMP4 Therapeutics Corporation Common Stock (CAMP)

What is CAMP4 Therapeutics Corporation Common Stock's Market Cap?: CAMP4 Therapeutics Corporation Common Stock's Market Cap is $276.1M, based on as-reported figures from SEC (XBRL) filings.
What is CAMP4 Therapeutics Corporation Common Stock's Price / Sales?: CAMP4 Therapeutics Corporation Common Stock's Price / Sales is 65.5×, based on as-reported figures from SEC (XBRL) filings.
What is CAMP4 Therapeutics Corporation Common Stock's Revenue (TTM)?: CAMP4 Therapeutics Corporation Common Stock's Revenue (TTM) is $4.2M, based on as-reported figures from SEC (XBRL) filings.
What is CAMP4 Therapeutics Corporation Common Stock's Net Income (TTM)?: CAMP4 Therapeutics Corporation Common Stock's Net Income (TTM) is -$107.2M, based on as-reported figures from SEC (XBRL) filings.
What is CAMP4 Therapeutics Corporation Common Stock's EBITDA?: CAMP4 Therapeutics Corporation Common Stock's EBITDA is -$51.1M, based on as-reported figures from SEC (XBRL) filings.
What is CAMP4 Therapeutics Corporation Common Stock's Diluted EPS (TTM)?: CAMP4 Therapeutics Corporation Common Stock's Diluted EPS (TTM) is -1.71, based on as-reported figures from SEC (XBRL) filings.
What is CAMP4 Therapeutics Corporation Common Stock's EBITDA Margin?: CAMP4 Therapeutics Corporation Common Stock's EBITDA Margin is -1211.0%, based on as-reported figures from SEC (XBRL) filings.